YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders
about
Differential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeatsTRDB--the Tandem Repeats DatabaseAn evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALSCTCF interacts with and recruits the largest subunit of RNA polymerase II to CTCF target sites genome-wideCombinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF.Specific sites in the C terminus of CTCF interact with the SA2 subunit of the cohesin complex and are required for cohesin-dependent insulation activityCharacterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137.We gather together: insulators and genome organization.The critical role of human transcriptional repressor CTCF mRNA up-regulation in the induction of anti-HIV-1 responses in CD4(+) T cellsNuclear organization in the 3D space of the nucleus - cause or consequence?YB-1: oncoprotein, prognostic marker and therapeutic target?Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action.3'poly-G-tailed ODNs inhibit F-spondin to induce cell death and neurite retraction in rat embryonic neurons.C2H2 Zinc Finger Proteins: The Largest but Poorly Explored Family of Higher Eukaryotic Transcription Factors.Looking Beyond the 5-HTTLPR Polymorphism: Genetic and Epigenetic Layers of Regulation Affecting the Serotonin Transporter Gene Expression.Allele-specific transcriptional activity of the variable number of tandem repeats in 5' region of the DRD4 gene is stimulus specific in human neuronal cells.Intronic tandem repeat in the serotonin transporter gene in Old World monkeys: a new transcriptional regulator?The SLC6A4 VNTR genotype determines transcription factor binding and epigenetic variation of this gene in response to cocaine in vitro.Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity.A regulatory domain spanning the repeat sequence RE1 from herpes simplex virus type 1 has cell specific differential functions in trigeminal neurons and fibroblasts.Simultaneous genotyping of multiple polymorphisms in human serotonin transporter gene and detection of novel allelic variants.SVA retrotransposons as modulators of gene expression.Association study of serotonin transporter gene polymorphisms and ventricular septal defects related possible pulmonary arterial hypertension in Chinese population.Allele-specific expression of the serotonin transporter and its transcription factors following lamotrigine treatment in vitro.MeCP2 and CTCF: enhancing the cross-talk of silencers.Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes.Conservation, evolution, and regulation of splicing during prefrontal cortex development in humans, chimpanzees and macaques.
P2860
Q24338948-24EDE53B-FE6C-4904-AD22-7A9D5A6F72D9Q24683650-FAEE3AF0-73F0-4380-8922-DD70238209EDQ31153726-50D5D98B-63D2-4276-9BE1-56F36D3B5727Q33268598-48B3F5AF-68DB-47DC-9947-DA520F7685D6Q33767378-7BF58B4D-F1AC-4F03-978B-BAA49919290AQ35096316-A57DFE81-3499-4B36-BB57-8E6CA6F044F3Q35369598-A472C425-EB4C-4975-BBD7-A857BC7702F9Q36407771-65B2B361-4306-40F5-85C8-BE0780C89B00Q36594233-0BE095FE-6606-4700-9A01-82F7A16672A7Q37486041-F1676B3A-64BC-4F11-A7B7-B65753C29607Q38065264-78D74369-315D-4232-AB88-CABBBE96F7EAQ38262202-25204A7B-93D0-4B9B-B1D0-39EAA856E57AQ38325257-00A1AE93-D8C5-4320-8362-D842445031E7Q38663289-B680E347-0AFB-4D5D-AF7E-E55C663A43D8Q39033887-7C5CCAF1-36D5-4534-8C8B-FEC62B85F13CQ39271114-E4E94FDD-653A-4177-92FF-6402F944DE37Q39450611-23BE09FF-BDFA-4A75-8701-C06490B49873Q39594641-EA4740F3-BB98-4F9E-870C-063B2C9E4F6BQ39664402-2D8CF79C-4C60-4759-8A5D-4706B3F36900Q41818656-1C24DA2F-5B00-4E52-A00E-0C18EEFCBF09Q41820255-A363440F-082C-4BED-B04D-38D909FB9A92Q42755409-51B8C8D8-6A5C-42C9-8873-7CB026275AFDQ43249309-0D05F09A-B38F-40DB-9BC0-0C9FF58C9E5EQ43849894-29BBE4F2-C7F5-44CE-8973-6616F98FEDC0Q45303510-CF86F034-788C-415D-9B11-8A5839D8F78EQ46404104-4303EF9C-E459-4612-8F2F-B3166D83992EQ47843240-38D77973-5167-4258-AC0B-E47BC2906AD6
P2860
YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
YB-1 and CTCF differentially r ...... iety of neurological disorders
@ast
YB-1 and CTCF differentially r ...... iety of neurological disorders
@en
YB-1 and CTCF differentially r ...... iety of neurological disorders
@en-gb
YB-1 and CTCF differentially r ...... iety of neurological disorders
@nl
type
label
YB-1 and CTCF differentially r ...... iety of neurological disorders
@ast
YB-1 and CTCF differentially r ...... iety of neurological disorders
@en
YB-1 and CTCF differentially r ...... iety of neurological disorders
@en-gb
YB-1 and CTCF differentially r ...... iety of neurological disorders
@nl
prefLabel
YB-1 and CTCF differentially r ...... iety of neurological disorders
@ast
YB-1 and CTCF differentially r ...... iety of neurological disorders
@en
YB-1 and CTCF differentially r ...... iety of neurological disorders
@en-gb
YB-1 and CTCF differentially r ...... iety of neurological disorders
@nl
P2093
P1476
YB-1 and CTCF differentially r ...... iety of neurological disorders
@en
P2093
Alison C Scott
Elena Klenova
Elizabeth A Lovejoy
Hans-Dieter Royer
Julian Roberts
Stephan Bergmann
Vivien J Bubb
P304
P356
10.1523/JNEUROSCI.1150-04.2004
P407
P577
2004-06-30T00:00:00Z